{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:25:13Z","timestamp":1793157913710,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11596-022-2673-6","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T22:02:28Z","timestamp":1671660148000},"page":"1111-1118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Overview of the 2022 WHO Classification of Pituitary Adenomas\/Pituitary Neuroendocrine Tumors: Clinical Practices, Controversies, and Perspectives"],"prefix":"10.1007","volume":"42","author":[{"given":"Xue-yan","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"2673_CR1","first-page":"406","volume-title":"WHO Classification of Tumours: Central Nervous System Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2021","unstructured":"WHO Classification of Tumours Editorial Board. Pituitary adenoma\/pituitary neuroendocrine tumour, In: WHO Classification of Tumours: Central Nervous System Tumours. Lyon: IARC. 2021:406\u2013415."},{"issue":"1","key":"2673_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, et al. Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr Pathol, 2022,33(1):6\u201326","journal-title":"Endocr Pathol"},{"issue":"3","key":"2673_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB. Overview of the 2017 WHO Classification of Pituitary Tumors. Endocr Pathol, 2017,28(3):228\u2013243","journal-title":"Endocr Pathol"},{"issue":"4","key":"2673_CR4","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/ERC-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Casar-Borota O, Chanson P, et al. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr Relat Cancer, 2017,24(4):C5\u2013C8","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"2673_CR5","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41379-021-00820-y","volume":"34","author":"SL Asa","year":"2021","unstructured":"Asa SL, Mete O, Cusimano MD, et al. Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification. Mod Pathol, 2021,34(9):1634\u20131650","journal-title":"Mod Pathol"},{"issue":"11","key":"2673_CR6","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1007\/s00701-021-04953-6","volume":"163","author":"S Ng","year":"2021","unstructured":"Ng S, Messerer M, Engelhardt J, et al. Aggressive pituitary neuroendocrine tumors: current practices, controversies, and perspectives, on behalf of the EANS skull base section. Acta Neurochir (Wien), 2021,163(11):3131\u20133142","journal-title":"Acta Neurochir (Wien)"},{"issue":"12","key":"2673_CR7","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol, 2018,31(12):1770\u20131786","journal-title":"Mod Pathol"},{"issue":"6","key":"2673_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11102-019-00988-2","volume":"22","author":"KKY Ho","year":"2019","unstructured":"Ho KKY, Fleseriu M, Wass J, et al. A tale of pituitary adenomas: to NET or not to NET: Pituitary Society position statement. Pituitary, 2019,22(6):569\u2013573","journal-title":"Pituitary"},{"issue":"3","key":"2673_CR9","doi-asserted-by":"publisher","first-page":"bvaa205","DOI":"10.1210\/jendso\/bvaa205","volume":"5","author":"K Ho","year":"2021","unstructured":"Ho K, Fleseriu M, Kaiser U, et al. Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time? J Endocr Soc, 2021,5(3):bvaa205","journal-title":"J Endocr Soc"},{"issue":"3","key":"2673_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11102-022-01235-x","volume":"25","author":"KKY Ho","year":"2022","unstructured":"Ho KKY, Gadelha M, Kaiser UB, et al. The NETting of pituitary adenoma: a gland illusion. Pituitary, 2022, 25(3):349\u2013351","journal-title":"Pituitary"},{"issue":"5","key":"2673_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000517356","volume":"112","author":"X Wan","year":"2022","unstructured":"Wan X, Yan Z, Tan Z, et al. MicroRNAs in Dopamine Agonist-Resistant Prolactinoma. Neuroendocrinology, 2022,112(5):417\u2013426","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2673_CR12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/cancers12020514","volume":"12","author":"J Trouillas","year":"2020","unstructured":"Trouillas J, Jaffrain-Rea ML, Vasiljevic A, et al. How to Classify the Pituitary Neuroendocrine Tumors (PitNET) s in 2020. Cancers (Basel), 2020,12(2):514","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2673_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.31083\/j.fbl2703077","volume":"27","author":"N Mouchtouris","year":"2022","unstructured":"Mouchtouris N, Smit RD, Piper K, et al. A review of multiomics platforms in pituitary adenoma pathogenesis. Front Biosci (Landmark Ed), 2022,27(3):77","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"2","key":"2673_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12022-020-09615-4","volume":"31","author":"J Turchini","year":"2020","unstructured":"Turchini J, Sioson L, Clarkson A, et al. Utility of GATA-3 Expression in the Analysis of Pituitary Neuroendocrine Tumour (PitNET) Transcription Factors. Endocr Pathol, 2020,31(2):150\u2013155","journal-title":"Endocr Pathol"},{"issue":"2","key":"2673_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10014-017-0307-7","volume":"35","author":"H Nishioka","year":"2018","unstructured":"Nishioka H and Inoshita N. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol, 2018,35(2):57\u201361","journal-title":"Brain Tumor Pathol"},{"issue":"2","key":"2673_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12022-021-09678-x","volume":"32","author":"SL Asa","year":"2021","unstructured":"Asa SL. Challenges in the Diagnosis of Pituitary Neuroendocrine Tumors. Endocr Pathol, 2021,32(2): 222\u2013227","journal-title":"Endocr Pathol"},{"issue":"7","key":"2673_CR17","doi-asserted-by":"publisher","first-page":"e0198877","DOI":"10.1371\/journal.pone.0198877","volume":"13","author":"A Garcia-Martinez","year":"2018","unstructured":"Garcia-Martinez A, Sottile J, Fajardo C, et al. Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours? PLoS One, 2018,13(7):e0198877","journal-title":"PLoS One"},{"issue":"3","key":"2673_CR18","first-page":"349","volume":"47","author":"MG Rojo","year":"2009","unstructured":"Rojo MG, Bueno G, Slodkowska J. Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice. Folia Histochem Cytobiol, 2009,47(3):349\u2013354","journal-title":"Folia Histochem Cytobiol"},{"issue":"12","key":"2673_CR19","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3390\/cancers11121990","volume":"11","author":"ME Torregrosa-Quesada","year":"2019","unstructured":"Torregrosa-Quesada ME, Garcia-Martinez A, Silva-Ortega S, et al. How Valuable Is the RT-qPCR of Pituitary-Specific Transcription Factors for Identifying Pituitary Neuroendocrine Tumor Subtypes According to the New WHO 2017 Criteria? Cancers (Basel), 2019,11(12):1990","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2673_CR20","doi-asserted-by":"publisher","first-page":"e0180039","DOI":"10.1371\/journal.pone.0180039","volume":"12","author":"L Sanchez-Tejada","year":"2017","unstructured":"Sanchez-Tejada L, Sanchez-Ortiga R, Lamas C, et al. Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas. PLoS One, 2017,12(7):e0180039","journal-title":"PLoS One"},{"issue":"1","key":"2673_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5858\/arpa.2016-0082-OA","volume":"141","author":"WC McDonald","year":"2017","unstructured":"McDonald WC, Banerji N, McDonald KN, et al. Steroidogenic Factor 1, Pit-1, and Adrenocorticotropic Hormone: A Rational Starting Place for the Immunohistochemical Characterization of Pituitary Adenoma. Arch Pathol Lab Med, 2017,141(1):104\u2013112","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"2673_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R, et al. Pangenomic Classification of Pituitary Neuroendocrine Tumors. Cancer Cell, 2020,37(1):123\u2013134, e125","journal-title":"Cancer Cell"},{"issue":"4","key":"2673_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00401-017-1768-9","volume":"134","author":"E Sjostedt","year":"2017","unstructured":"Sjostedt E, Bollerslev J, Mulder J, et al. A specific antibody to detect transcription factor T-Pit: a reliable marker of corticotroph cell differentiation and a tool to improve the classification of pituitary neuroendocrine tumours. Acta Neuropathol, 2017,134(4):675\u2013677","journal-title":"Acta Neuropathol"},{"issue":"6","key":"2673_CR24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00428-019-02655-0","volume":"475","author":"C Villa","year":"2019","unstructured":"Villa C, Vasiljevic A, Jaffrain-Rea ML, et al. A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal. Virchows Arch, 2019,475(6):687\u2013692","journal-title":"Virchows Arch"},{"key":"2673_CR25","doi-asserted-by":"publisher","first-page":"826720","DOI":"10.3389\/fsurg.2022.826720","volume":"9","author":"R Shi","year":"2022","unstructured":"Shi R, Wan X, Yan Z, et al. Clinicopathological Characteristics of Plurihormonal Pituitary Adenoma. Front Surg, 2022,9:826720","journal-title":"Front Surg"},{"issue":"1","key":"2673_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00401-005-1106-5","volume":"111","author":"R Fahlbusch","year":"2006","unstructured":"Fahlbusch R, Buslei R. The WHO classification of pituitary tumours: a combined neurosurgical and neuropathological view. Acta Neuropathol, 2006,111 (1):86\u201387","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2673_CR27","first-page":"610","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, et al. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery, 1993,33(4):610\u2013617; discussion 617\u2013618","journal-title":"Neurosurgery"},{"key":"2673_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jocn.2018.10.065","volume":"58","author":"L Lv","year":"2018","unstructured":"Lv L, Zhang B, Wang M, et al. Invasive pituitary adenomas with gross total resection: The wait-and-see policy during postoperative management. J Clin Neurosci, 2018,58:49\u201355","journal-title":"J Clin Neurosci"},{"issue":"9","key":"2673_CR29","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3390\/jcm11092464","volume":"11","author":"L Lu","year":"2022","unstructured":"Lu L, Wan X, Xu Y, et al. Classifying Pituitary Adenoma Invasiveness Based on Radiological, Surgical and Histological Features: A Retrospective Assessment of 903 Cases. J Clin Med, 2022,11(9):2464","journal-title":"J Clin Med"},{"issue":"11","key":"2673_CR30","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1007\/s00701-021-04912-1","volume":"163","author":"S Berkmann","year":"2021","unstructured":"Berkmann S, Lattmann J, Schuetz P, et al. The Shape grading system: a classification for growth patterns of pituitary adenomas. Acta Neurochir (Wien), 2021,163(11):3181\u20133189","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"2673_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/ons\/opy401","volume":"17","author":"MA Mooney","year":"2019","unstructured":"Mooney MA, Sarris CE, Zhou JJ, et al. Proposal and Validation of a Simple Grading Scale (TRANSSPHER Grade) for Predicting Gross Total Resection of Nonfunctioning Pituitary Macroadenomas After Transsphenoidal Surgery. Oper Neurosurg (Hagerstown), 2019,17(5):460\u2013469","journal-title":"Oper Neurosurg (Hagerstown)"},{"key":"2673_CR32","first-page":"18","volume":"65","author":"M Buchfelder","year":"1996","unstructured":"Buchfelder M, Fahlbusch R, Adams EF, et al. Proliferation parameters for pituitary adenomas. Acta Neurochir Suppl, 1996,65:18\u201321","journal-title":"Acta Neurochir Suppl"},{"key":"2673_CR33","doi-asserted-by":"publisher","first-page":"106176","DOI":"10.1016\/j.clineuro.2020.106176","volume":"197","author":"C Li","year":"2020","unstructured":"Li C, Zhu H, Zong X, et al. Experience of trans-nasal endoscopic surgery for pituitary tumors in a single center in China: Surgical results in a cohort of 2032 patients, operated between 2006 and 2018. Clin Neurol Neurosurg, 2020,197:106176","journal-title":"Clin Neurol Neurosurg"},{"issue":"22","key":"2673_CR34","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1158\/1078-0432.CCR-18-0472","volume":"24","author":"H Zhu","year":"2018","unstructured":"Zhu H, Guo J, Shen Y, et al. Functions and Mechanisms of Tumor Necrosis Factor-alpha and Noncoding RNAs in Bone-Invasive Pituitary Adenomas. Clin Cancer Res, 2018,24(22):5757\u20135766","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2673_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11154-020-09563-8","volume":"21","author":"M Buchfelder","year":"2020","unstructured":"Buchfelder M, Schlaffer SM. Surgical treatment of aggressive pituitary adenomas and pituitary carcinomas. Rev Endocr Metab Disord, 2020,21(2):253\u2013261","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"2673_CR36","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3390\/diagnostics12040977","volume":"12","author":"L Lu","year":"2022","unstructured":"Lu L, Wan X, Xu Y, et al. Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions. Diagnostics (Basel), 2022,12(4):977","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"2673_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1530\/eje.1.01863","volume":"152","author":"P Nomikos","year":"2005","unstructured":"Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical \u2018cure\u2019. Eur J Endocrinol, 2005,152(3):379\u2013387","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2673_CR38","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3171\/JNS\/2008\/108\/4\/0736","volume":"108","author":"EF Chang","year":"2008","unstructured":"Chang EF, Zada G, Kim S, et al. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. J Neurosurg, 2008,108(4):736\u2013745","journal-title":"J Neurosurg"},{"issue":"9","key":"2673_CR39","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/BF03347568","volume":"28","author":"AL Machado","year":"2005","unstructured":"Machado AL, Nomikos P, Kiesewetter F, et al. DNA-flow cytometry of 207 pituitary adenomas: ploidy, proliferation, and prognosis. J Endocrinol Invest, 2005,28(9):795\u2013801","journal-title":"J Endocrinol Invest"},{"issue":"17","key":"2673_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00029679-198911170-00001","volume":"11","author":"R Fahlbusch","year":"1989","unstructured":"Fahlbusch R, Buchfelder M. Current Management of Invasive Pituitary Adenomas. Contemp Neurosurg, 1989,11(17):1\u20136","journal-title":"Contemp Neurosurg"},{"key":"2673_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-3-642-77109-5_67","volume":"20","author":"M Buchfelder","year":"1992","unstructured":"Buchfelder M, Fahlbusch R, Adams EF, et al. Growth Characteristics and Proliferation Parameters of Invasive Pituitary Adenomas. Adv Neurosurg, 1992,20:381\u2013386","journal-title":"Adv Neurosurg"},{"issue":"2","key":"2673_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/BF02888236","volume":"17","author":"T Lei","year":"1997","unstructured":"Lei T, Xue D, Adams EF, et al. Relationship between invasiveness of pituitary somatotrophinomas and structural abnormalities of protein kinase C gene in human. J Tongji Med Univ, 1997,17(2):68\u201371","journal-title":"J Tongji Med Univ"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-022-2673-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-022-2673-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-022-2673-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T11:11:34Z","timestamp":1672312294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-022-2673-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2673"],"URL":"https:\/\/doi.org\/10.1007\/s11596-022-2673-6","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"10 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}},{"value":"Author Ting LEI is a member of the Editorial Board for Current Medical Science. The paper was handled by other editors and has undergone rigorous peer review process. Author Ting LEI was not involved in the journal\u2019s review of, or decisions related to, this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}